DAPTOMICINA MIP 350mg powder for injection / infusion solution medication leaflet

J01XX09 daptomycin • Antiinfectives for systemic use | Other antibacterials

Daptomycinum is an antibiotic used for the treatment of serious bacterial infections caused by Gram-positive bacteria, including skin infections, soft tissue infections, and bacteremia. It works by disrupting the bacterial cell membrane, leading to cell death.

The medication is administered intravenously and is particularly indicated for infections caused by resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). It is effective in treating complicated infections.

Side effects may include muscle pain, nausea, diarrhea, and, in rare cases, rhabdomyolysis. Monitoring kidney function and creatine kinase levels during treatment is essential.

Consult your doctor before use, especially if you have kidney conditions or are taking other medications. Use Daptomycinum as directed to ensure treatment effectiveness.

General data about DAPTOMICINA MIP 350mg

Substance: daptomycin

Date of last drug list: 01-06-2025

Commercial code: W71138002

Concentration: 350mg

Pharmaceutical form: powder for injection / infusion solution

Quantity: 5

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MIP PHARMA GMBH - GERMANIA

Holder: MIP PHARMA GMBH - GERMANIA

Number: 16035/2025/02

Shelf life: 3 years-after packing for marketing;after reconstitution-it is used immediately

Concentrations available for daptomycin

350mg, 500mg